Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Terveellisiin tapoihin perustuvat koulutusohjelmat elämänlaadun ja psykososiaalisen profiilin parantamiseksi naisilla, joilla on neurodegeneratiivisia sairauksia: neuvontaprotokollatutkimus (vaihe 2) (ADVICE Phase 2)

tiistai 29. syyskuuta 2026 päivittänyt: Jacobo Á. Rubio-Arias, Universidad de Almeria

Terveellisiin tapoihin perustuvat koulutusohjelmat elämänlaadun ja psykososiaalisen profiilin parantamiseksi naisilla, joilla on neurodegeneratiivisia sairauksia: neuvontaprotokollatutkimus

This phase of the project aims to compare in-person, supervised educational programs (EP) with online self-guided EPs in individuals with relapsing-remitting multiple sclerosis. A total of 75 participants will be randomly assigned to one of three groups: a supervised and individualized educational program focused on HIIT training, a supervised and individualized educational program focused on strength training, and a non-supervised, self-guided educational program based on resistance band training. Additionally, sessions on the Mediterranean diet (both supervised and non-supervised) and cognitive-behavioral interventions will be included. A control evaluation will be conducted three months after the intervention to assess the effects of the educational programs, followed by another evaluation three months later to analyze residual effects. Women who participated in Phase 1 of the study will be invited to take part in this second phase.

Tutkimuksen yleiskatsaus

Opintotyyppi

Interventio

Ilmoittautuminen (Todellinen)

40

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskelupaikat

    • Murcia
      • Murcia, Murcia, Espanja, 30120
        • Hospital Universitario Virgen de la Arrixaca

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

18 vuotta - 50 vuotta (Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Ei

Sukupuolet, jotka voivat opiskella

Kaikki

Kuvaus

Inclusion criteria include:

  • Women and men of reproductive age (18-45 years) with MS will be included, with the upper age limit adjusted to reflect the reproductive phase;
  • no iron-deficiency anemia;
  • stable disease phase;
  • independent walking ability for over 10 meters.

Women will be recruited first and later matched with men based on age, EDSS, and lifestyle habits (physical activity, smoking, and alcohol consumption).

Exclusion criteria will include participants with MS who:

  • score <1 or >6 on the EDSS;
  • report a relapse within 12 months before the study begins;
  • have taken corticosteroid treatment within the last 2 months;
  • have participated in a structured training program in the previous 6 months.

Once all women with MS are recruited, male participants will be recruited following a 1:1 matching methodology based on age, geographic region, and lifestyle habits.

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Tukevaa hoitoa
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Kolminkertaistaa

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Kokeellinen: Supervised Strength Training Program (PE1)

Participants will complete 36 strength sessions (3 times a week) at a moderate intensity, 6 educational nutritional intervention sessions, and 8 sessions on energy and fatigue management.

This arm of the study consists of a supervised strength training program, conducted over 12 weeks with three weekly sessions. The sessions follow a wave-like periodization, with intensities ranging from 70% to 85% of 1-RM. Exercises focus on enhancing neuromuscular strength in the lower limbs, such as leg presses and hip extensions, under the supervision of a multidisciplinary team.

Participants will also receive nutritional guidance based on the Mediterranean diet, as well as cognitive-behavioral therapy strategies aimed at optimizing fatigue management and boosting energy levels.

Active Comparator: Self-Guided and Unsupervised Program with General Recommendations (PE1)

Participants will be involved in an unsupervised, self-directed program focusing on physical exercise (three times per week), nutrition and cognitive-behavioral habits.

This arm of the study consists of a self-guided and unsupervised program based on physical exercise (3 times per week), nutrition, and cognitive-behavioral habits. Participants will access online modules that provide guidelines for performing resistance exercises with bands, dietary recommendations following the principles of the Mediterranean diet, and cognitive-behavioral techniques for fatigue management.

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Satisfaction with Physical Activity
Aikaikkuna: Baseline (pre-intervention)

Satisfaction with Physical Activity will be measured using an eight-item, 5-point Likert scale

Baseline (pre-intervention)
Satisfaction with Physical Activity
Aikaikkuna: Immediately after the intervention

Satisfaction with Physical Activity will be measured using an eight-item, 5-point Likert scale

Immediately after the intervention
Visual Analogue Scale for Fatigue (VAS-F)
Aikaikkuna: Immediately before each of the 36 exercise sessions (pre-session assessment).

The Visual Analogue Scale for Fatigue (VAS-F) assesses subjective levels of fatigue and energy

Immediately before each of the 36 exercise sessions (pre-session assessment).
Visual Analogue Scale for Fatigue (VAS-F)
Aikaikkuna: Immediately after each of the 36 exercise sessions (post-session assessment).

The Visual Analogue Scale for Fatigue (VAS-F) assesses subjective levels of fatigue and energy

Immediately after each of the 36 exercise sessions (post-session assessment).
Modified Fatigue Impact Scale (MFIS)
Aikaikkuna: Baseline (pre-intervention).

Fatigue perception will be measured using the MFIS. This scale is a 21-item multidimensional questionnaire that evaluates the physical, cognitive, and psychosocial effects of fatigue on a five-point ordinal scale (with a maximum total score of 84).

Baseline (pre-intervention).
Modified Fatigue Impact Scale (MFIS)
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

Fatigue perception will be measured using the MFIS. This scale is a 21-item multidimensional questionnaire that evaluates the physical, cognitive, and psychosocial effects of fatigue on a five-point ordinal scale (with a maximum total score of 84)

48 hours after the last exercise session (post-intervention assessment).

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Inflammatory Profile
Aikaikkuna: Baseline (pre-intervention).

The inflammatory profile evaluates key cytokines, including IFN-γ, IL-6, TNF-α, IL-10, and TGF-β1, to assess systemic inflammation and immune response dynamics

Baseline (pre-intervention).
Inflammatory Profile
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

The inflammatory profile evaluates key cytokines, including IFN-γ, IL-6, TNF-α, IL-10, and TGF-β1, to assess systemic inflammation and immune response dynamics

48 hours after the last exercise session (post-intervention assessment).
The hormonal profile
Aikaikkuna: Pre-intervention in each phase of the menstrual cycle (early follicular phase, late follicular phase and mid-luteal phase).

The hormonal profile includes the assessment of TSH, progesterone (PG), luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, and testosterone to evaluate endocrine function, menstrual cycle phases, and hormonal balance.

Pre-intervention in each phase of the menstrual cycle (early follicular phase, late follicular phase and mid-luteal phase).
Cognitive Function
Aikaikkuna: Baseline (pre-intervention).

Brain-Derived Neurotrophic Factor (BDNF) is a protein involved in neuroplasticity, cognitive function, and neuronal survival, serving as a blood biomarker for brain health and adaptability.

Baseline (pre-intervention).
Cognitive Function
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

Brain-Derived Neurotrophic Factor (BDNF) is a protein involved in neuroplasticity, cognitive function, and neuronal survival, serving as a blood biomarker for brain health and adaptability

48 hours after the last exercise session (post-intervention assessment).
Neurofilament Light Chain (NFL)
Aikaikkuna: Baseline (pre-intervention).

Neurofilament light chain (NFL) is one of the most relevant biomarkers in multiple sclerosis (MS). The Simoa detection technique (ultrasensitive single-molecule array) allows its analysis in serum, providing both the total value and the Z-Score, enabling precise assessment of axonal damage and disease progression.

Baseline (pre-intervention).
Neurofilament Light Chain (NFL)
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

Neurofilament light chain (NFL) is one of the most relevant biomarkers in multiple sclerosis (MS). The Simoa detection technique (ultrasensitive single-molecule array) allows its analysis in serum, providing both the total value and the Z-Score, enabling precise assessment of axonal damage and disease progression.

48 hours after the last exercise session (post-intervention assessment).
Physical Self-Perception
Aikaikkuna: Baseline (pre-intervention).

Physical self-perception will be evaluated using six subscales-sports competence, physical condition, body attractiveness, physical strength, general physical self-perception, and overall self-perception-on a 5-point Likert scale

Baseline (pre-intervention).
Physical Self-Perception
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

Physical self-perception will be evaluated using six subscales-sports competence, physical condition, body attractiveness, physical strength, general physical self-perception, and overall self-perception-on a 5-point Likert scale

48 hours after the last exercise session (post-intervention assessment).
Walking Endurance
Aikaikkuna: Baseline (pre-intervention).

Participants will undergo the 2-minute walk test, during which they will walk at their preferred, self-selected speed to assess walking endurance. The test course will be rectangular, with corners marked by cones. Participants will be allowed to rest during the test, if necessary, but the clock will not stop during these rest periods. The total distance covered will be recorded

Baseline (pre-intervention).
Walking Endurance
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

Participants will undergo the 2-minute walk test, during which they will walk at their preferred, self-selected speed to assess walking endurance. The test course will be rectangular, with corners marked by cones. Participants will be allowed to rest during the test, if necessary, but the clock will not stop during these rest periods. The total distance covered will be recorded

48 hours after the last exercise session (post-intervention assessment).
Pain Catastrophizing
Aikaikkuna: Baseline (pre-intervention).

The Pain Catastrophizing Scale will measure catastrophic thoughts related to pain, focusing on rumination and helplessness, with responses on a similar scale

Baseline (pre-intervention).
Pain Catastrophizing
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

The Pain Catastrophizing Scale will measure catastrophic thoughts related to pain, focusing on rumination and helplessness, with responses on a similar scale

48 hours after the last exercise session (post-intervention assessment).
Quality of Life questionnaire
Aikaikkuna: Baseline (pre-intervention).

The Multiple Sclerosis Quality of Life-54 will gauge quality of life across 14 subscales, yielding physical and mental health composite scores

Baseline (pre-intervention).
Quality of Life questionnaire
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

The Multiple Sclerosis Quality of Life-54 will gauge quality of life across 14 subscales, yielding physical and mental health composite scores

48 hours after the last exercise session (post-intervention assessment).
State-Trait Anxiety
Aikaikkuna: Baseline (pre-intervention).

Description: The State-Trait Anxiety Inventory will measure both situational and general anxiety on a 4-point scale

Baseline (pre-intervention).
State-Trait Anxiety
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

The State-Trait Anxiety Inventory will measure both situational and general anxiety on a 4-point scaleTime Frame: Before the first training session

48 hours after the last exercise session (post-intervention assessment).
Rate of force development
Aikaikkuna: Baseline (pre-intervention).

Participants will sit in a chair with both legs flexed at a 90-degree angle, and the tested ankle securely attached to a customized device with a load cell (MuscleLab Force Sensor, Ergotest AS, Langesund, Norway). They will perform three maximum contractions, each lasting 2 seconds, with 3 minutes of rest in between. The RFD will be analyzed. Testing will begin with the right leg, and the repetition with the highest recorded value for each leg will be used in the analysis

Baseline (pre-intervention).
Rate of force development
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

Participants will sit in a chair with both legs flexed at a 90-degree angle, and the tested ankle securely attached to a customized device with a load cell (MuscleLab Force Sensor, Ergotest AS, Langesund, Norway). They will perform three maximum contractions, each lasting 2 seconds, with 3 minutes of rest in between. The RFD will be analyzed. Testing will begin with the right leg, and the repetition with the highest recorded value for each leg will be used in the analysis

48 hours after the last exercise session (post-intervention assessment).
Maximum Voluntary Isometric Contraction
Aikaikkuna: Baseline (pre-intervention).

Participants will sit in a chair with both legs flexed at a 90-degree angle, and the tested ankle securely attached to a customized device with a load cell (MuscleLab Force Sensor, Ergotest AS, Langesund, Norway).Participants will perform three 5-second MVIC, with 3 minutes of rest in between. Testing will always begin with the right leg, and the contraction with the highest recorded MVIC value will be used in the analysis Time Frame: Before the first training session

Baseline (pre-intervention).
Maximum Voluntary Isometric Contraction
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

Participants will sit in a chair with both legs flexed at a 90-degree angle, and the tested ankle securely attached to a customized device with a load cell (MuscleLab Force Sensor, Ergotest AS, Langesund, Norway).Participants will perform three 5-second MVIC, with 3 minutes of rest in between. Testing will always begin with the right leg, and the contraction with the highest recorded MVIC value will be used in the analysis Time Frame: Before the first training session

48 hours after the last exercise session (post-intervention assessment).
Maximal neural drive
Aikaikkuna: Baseline (pre-intervention).

To measure neural drive, the electromyographic activity (sEMG) of the right leg's vastus lateralis will be recorded during the MVIC (Delsys Trigno, Delsys Inc., Boston, MA) with skin prepared and electrode positioning following SENIAM guidelines. EMG peak will be analyzed. The EMG peak during MVIC will represent the maximum neural drive

Baseline (pre-intervention).
Maximal neural drive
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

To measure neural drive, the electromyographic activity (sEMG) of the right leg's vastus lateralis will be recorded during the MVIC (Delsys Trigno, Delsys Inc., Boston, MA) with skin prepared and electrode positioning following SENIAM guidelines. EMG peak will be analyzed. The EMG peak during MVIC will represent the maximum neural drive

48 hours after the last exercise session (post-intervention assessment).
Central activation ratio
Aikaikkuna: Baseline (pre-intervention).

Two bipolar electrodes (10×15 cm) will be placed on the right quadriceps, with electrical stimulation controlled by Signal 6.0 software (CED, Cambridge, England) at 100 Hz frequency, 50 pulses, 0.009 s pulse duration, and 0.01 s interval, set to 40-50% of MVIC. Central activation ratio (CAR) will be assessed through a sequence of one supramaximal twitch, a 100 Hz tetanic train, an MVIC with superimposed tetanic train, followed by a potentiated tetanic train and a potentiated supramaximal twitch. This sequence will be repeated twice with 2-minute rests, and twitch-to-tetanus ratio, MVIC peak, and maximum force values will be calculated for CAR. The CAR will be calculated using the following formula: "CAR= " "Force during MVIC" /"Force during MVIC + supramaximal stimulation"

Baseline (pre-intervention).
Central activation ratio
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

Two bipolar electrodes (10×15 cm) will be placed on the right quadriceps, with electrical stimulation controlled by Signal 6.0 software (CED, Cambridge, England) at 100 Hz frequency, 50 pulses, 0.009 s pulse duration, and 0.01 s interval, set to 40-50% of MVIC. Central activation ratio (CAR) will be assessed through a sequence of one supramaximal twitch, a 100 Hz tetanic train, an MVIC with superimposed tetanic train, followed by a potentiated tetanic train and a potentiated supramaximal twitch. This sequence will be repeated twice with 2-minute rests, and twitch-to-tetanus ratio, MVIC peak, and maximum force values will be calculated for CAR. The CAR will be calculated using the following formula: "CAR= " "Force during MVIC" /"Force during MVIC + supramaximal stimulation"

48 hours after the last exercise session (post-intervention assessment).
Upper Limb Maximum Strength
Aikaikkuna: Baseline (pre-intervention).

Isometric grip strength will be measured with an electronic dynamometer (K-Force Grip, Kinvent, Montpellier, France) as participants stand with elbows extended. Each hand will perform 3 trials, with 30 seconds rest between attempts

Baseline (pre-intervention).
Upper Limb Maximum Strength
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

Isometric grip strength will be measured with an electronic dynamometer (K-Force Grip, Kinvent, Montpellier, France) as participants stand with elbows extended. Each hand will perform 3 trials, with 30 seconds rest between attempts

48 hours after the last exercise session (post-intervention assessment).
Spasticity
Aikaikkuna: Before the first session of the intervention program

The Pendulum Test is used to assess the level of spasticity by evaluating the resistance to passive movement in the affected limb. The test involves moving the limb in a pendulum-like motion and observing the fluidity of the movement, with increased resistance indicating higher spasticity levels

Before the first session of the intervention program
Spasticity
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

The Pendulum Test is used to assess the level of spasticity by evaluating the resistance to passive movement in the affected limb. The test involves moving the limb in a pendulum-like motion and observing the fluidity of the movement, with increased resistance indicating higher spasticity levels

48 hours after the last exercise session (post-intervention assessment).
Intrinsic muscle characteristics
Aikaikkuna: Baseline (pre-intervention).

Muscle characteristics (frequency, stiffness, degradation) assessed with MyotonPRO (MyotonPRO, Myoton AS, Estonia)

Baseline (pre-intervention).
Intrinsic muscle characteristics
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

Muscle characteristics (frequency, stiffness, degradation) assessed with MyotonPRO (MyotonPRO, Myoton AS, Estonia)

48 hours after the last exercise session (post-intervention assessment).
Gait speed
Aikaikkuna: Baseline (pre-intervention).

Gait speed will be determined with the 10-meter walk test using two photocells (Ergotest Technology AS, Langesund, Norway) at 5 and 10 meters; participants will complete two maximum-speed trials, with the slower time recorded

Baseline (pre-intervention).
Gait speed
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

Gait speed will be determined with the 10-meter walk test using two photocells (Ergotest Technology AS, Langesund, Norway) at 5 and 10 meters; participants will complete two maximum-speed trials, with the slower time recorded

48 hours after the last exercise session (post-intervention assessment).
Static balance with eyes open
Aikaikkuna: Baseline (pre-intervention).

Balance is measured with static trials on a force platform (Ergotest Technology AS, Langesund, Norway), where participants stand barefoot with arms at their sides for two 30-second trials each

Baseline (pre-intervention).
Static balance with eyes open
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

Balance is measured with static trials on a force platform (Ergotest Technology AS, Langesund, Norway), where participants stand barefoot with arms at their sides for two 30-second trials each

48 hours after the last exercise session (post-intervention assessment).
Static balance with eyes closed
Aikaikkuna: Baseline (pre-intervention).

Balance is measured with static trials on a force platform (Ergotest Technology AS, Langesund, Norway), where participants stand barefoot with arms at their sides for two 30-second trials each

Baseline (pre-intervention).
Static balance with eyes closed
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

Balance is measured with static trials on a force platform (Ergotest Technology AS, Langesund, Norway), where participants stand barefoot with arms at their sides for two 30-second trials each

48 hours after the last exercise session (post-intervention assessment).
Sit-to-stand
Aikaikkuna: Baseline (pre-intervention).

The sit-to-stand test requires participants to rise as quickly as possible from a seated position with 90º knee flexion and arms crossed

Baseline (pre-intervention).
Sit-to-stand
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

The sit-to-stand test requires participants to rise as quickly as possible from a seated position with 90º knee flexion and arms crossed

48 hours after the last exercise session (post-intervention assessment).
Timed Up-and-Go test
Aikaikkuna: Baseline (pre-intervention).

In the Timed Up-and-Go test, participants move from sitting to standing, walk 3 meters, turn, return, and sit

Baseline (pre-intervention).
Timed Up-and-Go test
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

In the Timed Up-and-Go test, participants move from sitting to standing, walk 3 meters, turn, return, and sit

48 hours after the last exercise session (post-intervention assessment).
Delayed onset muscle soreness
Aikaikkuna: Baseline (pre-intervention).

To measure delayed onset muscle soreness (DOMS), a 10-point visual analogue scale shall be used, where 1 = no pain and 10 = intolerable pain

Baseline (pre-intervention).
Subjective Perception of Effort
Aikaikkuna: Baseline (pre-intervention).

Participants will be instructed and familiarized with the use of the RPE scale during the familiarization phase. RPE will be assessed before, during (after each exercise within the session), and after the training session using the Borg 6-20 RPE scale

Baseline (pre-intervention).
Fatigue Visual Analog Scale (VAS-F)
Aikaikkuna: Baseline (pre-intervention).

The VAS-F will be used to measure fatigue. This scale, is subdivided into two subscales: fatigue and energy. The VAS-F features a 100 mm long horizontal line, with the term "none" at one end and "very severe" at the opposite end. Participants are required to mark the point on the line corresponding to their perception of the severity of fatigue between these two endpoints.

Baseline (pre-intervention).
Anthropometric
Aikaikkuna: Baseline (pre-intervention).

Anthropometric measurements will be taken to assess body morphology, fat distribution, and potential alterations due to multiple sclerosis (MS), such as muscle atrophy or changes in body fat percentage. These measurements provide valuable information regarding comorbidities, including abdominal obesity and cardiovascular risk, which are particularly relevant in MS due to factors like reduced mobility or medication use

Baseline (pre-intervention).
Anthropometric
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

Anthropometric measurements will be taken to assess body morphology, fat distribution, and potential alterations due to multiple sclerosis (MS), such as muscle atrophy or changes in body fat percentage. These measurements provide valuable information regarding comorbidities, including abdominal obesity and cardiovascular risk, which are particularly relevant in MS due to factors like reduced mobility or medication use

48 hours after the last exercise session (post-intervention assessment).
Bioimpedance
Aikaikkuna: Baseline (pre-intervention).

Bioimpedance will be used to assess body composition, including body fat percentage, lean mass, and total body water. These measurements are important for understanding changes in body composition due to multiple sclerosis (MS), as the disease can impact muscle mass, fluid balance, and fat distribution. Bioimpedance provides valuable insight into the health status and nutritional needs of individuals with MS

Baseline (pre-intervention).
Bioimpedance
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

Bioimpedance will be used to assess body composition, including body fat percentage, lean mass, and total body water. These measurements are important for understanding changes in body composition due to multiple sclerosis (MS), as the disease can impact muscle mass, fluid balance, and fat distribution. Bioimpedance provides valuable insight into the health status and nutritional needs of individuals with MS

48 hours after the last exercise session (post-intervention assessment).
Physical Activity Levels
Aikaikkuna: Baseline (pre-intervention).

To assess physical activity in patients with multiple sclerosis (MS), both the International Physical Activity Questionnaire (IPAQ) and triaxial accelerometers can be adapted to account for the mobility limitations often experienced by these individuals. The IPAQ can be tailored by including questions that specifically address low-impact or moderate-intensity activities, considering factors such as fatigue and muscle weakness. Triaxial accelerometers, which measure movement in three planes (vertical, lateral, and anterior-posterior), provide a more detailed and precise measurement of physical activity, capturing even small movements or low-intensity activities such as walking short distances. Together, these tools allow for a comprehensive assessment of physical activity levels in MS patients, while considering their unique needs and capabilities. Additionally, the MET (Metabolic Equivalent of Task) methodology should be adjusted to reflect the lower intensity of activities commonly p

Baseline (pre-intervention).
Physical Activity Levels
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

To assess physical activity in patients with multiple sclerosis (MS), both the International Physical Activity Questionnaire (IPAQ) and triaxial accelerometers can be adapted to account for the mobility limitations often experienced by these individuals. The IPAQ can be tailored by including questions that specifically address low-impact or moderate-intensity activities, considering factors such as fatigue and muscle weakness. Triaxial accelerometers, which measure movement in three planes (vertical, lateral, and anterior-posterior), provide a more detailed and precise measurement of physical activity, capturing even small movements or low-intensity activities such as walking short distances. Together, these tools allow for a comprehensive assessment of physical activity levels in MS patients, while considering their unique needs and capabilities. Additionally, the MET (Metabolic Equivalent of Task) methodology should be adjusted to reflect the lower intensity of activities commonly p

48 hours after the last exercise session (post-intervention assessment).
Dietary and Nutritional Follow-up
Aikaikkuna: Baseline (pre-intervention).

Mediterranean Diet adherence questionnaires and food diaries could be effective tools for evaluating nutrition, particularly if MS patients have poor consumption of essential nutrients for their overall health

Baseline (pre-intervention).
Dietary and Nutritional Follow-up
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

Mediterranean Diet adherence questionnaires and food diaries could be effective tools for evaluating nutrition, particularly if MS patients have poor consumption of essential nutrients for their overall health

48 hours after the last exercise session (post-intervention assessment).
The Kurtzke Disability Scale
Aikaikkuna: Baseline (pre-intervention).

The Kurtzke Disability Scale (EDSS) is divided into 8 functional systems (FS); four primary: pyramidal function, cerebellar function, sensory function, and brainstem function; and four secondary: sphincters, vision, mental, and others. For each FS, a severity score is provided, ranging from 0 to 6 or 7. The overall score of the scale is measured on a 20-item scale (from 0 to 10 points, increasing in half-point increments). Up to 3.5, the score obtained in each FS and the number of affected FS automatically determine the EDSS score. From 4 to 7, the definition of each level is also given by the ability to walk (ability to walk without stopping, need for assistance)

Baseline (pre-intervention).
The Kurtzke Disability Scale
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

The Kurtzke Disability Scale (EDSS) is divided into 8 functional systems (FS); four primary: pyramidal function, cerebellar function, sensory function, and brainstem function; and four secondary: sphincters, vision, mental, and others. For each FS, a severity score is provided, ranging from 0 to 6 or 7. The overall score of the scale is measured on a 20-item scale (from 0 to 10 points, increasing in half-point increments). Up to 3.5, the score obtained in each FS and the number of affected FS automatically determine the EDSS score. From 4 to 7, the definition of each level is also given by the ability to walk (ability to walk without stopping, need for assistance).

48 hours after the last exercise session (post-intervention assessment).
Subjective Sleep Quality Questionnaire
Aikaikkuna: Baseline (pre-intervention).

Subjective sleep quality will be measured using the Karolinska Sleep Diary questionnaire [73]. The questionnaire includes the following items: a) sleep quality (very poor [1] - very good [5]), b) sleep tranquility (very restless [1] - very calm [5]), c) ease of falling asleep (very difficult [1] - very easy [5]), d) awakenings (woke up too early [1] - did not wake up early [3]), e) ease of waking up (very difficult [1] - very easy [5]), f) feeling of rest (did not rest at all [1] - fully rested [3]), and g) sufficient sleep (no, definitely too little [1] - yes, definitely enough [5]).

Baseline (pre-intervention).
Subjective Sleep Quality Questionnaire
Aikaikkuna: 48 hours after the last exercise session (post-intervention assessment).

Subjective sleep quality will be measured using the Karolinska Sleep Diary questionnaire [73]. The questionnaire includes the following items: a) sleep quality (very poor [1] - very good [5]), b) sleep tranquility (very restless [1] - very calm [5]), c) ease of falling asleep (very difficult [1] - very easy [5]), d) awakenings (woke up too early [1] - did not wake up early [3]), e) ease of waking up (very difficult [1] - very easy [5]), f) feeling of rest (did not rest at all [1] - fully rested [3]), and g) sufficient sleep (no, definitely too little [1] - yes, definitely enough [5]).

48 hours after the last exercise session (post-intervention assessment).
Sleep Quality Measured by Actigraph
Aikaikkuna: The week prior to the start of the intervention. Baseline (pre-intervention).

Sleep quality based on actigraphy will be evaluated using the Actiwatch wGT3X-BT activity monitoring system (Cambridge Neurotechnology, Cambridge, UK) [74]. This device uses a piezoelectric accelerometer to measure activity. Participants will wear the Actiwatch on their non-dominant wrist. The lower sensitivity threshold for actigraphy will be set at 80 counts/epoch. Data analysis will begin at the start of the nighttime rest period (bedtime) and conclude at the start of daytime activity (wake-up time).

The week prior to the start of the intervention. Baseline (pre-intervention).
Sleep Quality Measured by Actigraph
Aikaikkuna: The week following the completion of the intervention (post-intervention assessment).

Sleep quality based on actigraphy will be evaluated using the Actiwatch wGT3X-BT activity monitoring system (Cambridge Neurotechnology, Cambridge, UK) [74]. This device uses a piezoelectric accelerometer to measure activity. Participants will wear the Actiwatch on their non-dominant wrist. The lower sensitivity threshold for actigraphy will be set at 80 counts/epoch. Data analysis will begin at the start of the nighttime rest period (bedtime) and conclude at the start of daytime activity (wake-up time)

The week following the completion of the intervention (post-intervention assessment).
Delayed onset muscle soreness
Aikaikkuna: Immediately after each physical exercise session (post-intervention assessment).

To measure delayed onset muscle soreness (DOMS), a 10-point visual analogue scale shall be used, where 1 = no pain and 10 = intolerable pain

Immediately after each physical exercise session (post-intervention assessment).
Subjective Perception of Effort
Aikaikkuna: Immediately after each physical exercise session (post-intervention assessment).

Participants will be instructed and familiarized with the use of the RPE scale during the familiarization phase. RPE will be assessed before, during (after each exercise within the session), and after the training session using the Borg 6-20 RPE scale

Immediately after each physical exercise session (post-intervention assessment).
Fatigue Visual Analog Scale (VAS-F)
Aikaikkuna: Immediately after each physical exercise session (post-intervention assessment).

The VAS-F will be used to measure fatigue. This scale, is subdivided into two subscales: fatigue and energy. The VAS-F features a 100 mm long horizontal line, with the term "none" at one end and "very severe" at the opposite end. Participants are required to mark the point on the line corresponding to their perception of the severity of fatigue between these two endpoints.

Immediately after each physical exercise session (post-intervention assessment).

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Julkaisuja ja hyödyllisiä linkkejä

Tutkimusta koskevien tietojen syöttämisestä vastaava henkilö toimittaa nämä julkaisut vapaaehtoisesti. Nämä voivat koskea mitä tahansa tutkimukseen liittyvää.

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Tiistai 15. huhtikuuta 2025

Ensisijainen valmistuminen (Todellinen)

Sunnuntai 15. kesäkuuta 2025

Opintojen valmistuminen (Todellinen)

Tiistai 28. heinäkuuta 2026

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Torstai 20. helmikuuta 2025

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Torstai 13. maaliskuuta 2025

Ensimmäinen Lähetetty (Todellinen)

Keskiviikko 19. maaliskuuta 2025

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Keskiviikko 30. syyskuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Tiistai 29. syyskuuta 2026

Viimeksi vahvistettu

Tiistai 1. syyskuuta 2026

Lisää tietoa

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa